Los Cerros begins drilling newly identified target

|

Published 27-APR-2021 11:06 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Los Cerros Ltd (ASX:LCL) has today commenced drilling at its newly identified porphyry target (Ceibal) ~1km southwest of Tesorito.

The emerging gold-copper play has embarked on its largest year of exploration drilling to date, with a view to uncovering the true size potential of its Tesorito and Chuscal porphyry prospects at its Quinchia Project in Colombia, , a cluster of porphyry targets surrounding the Miraflores Gold Deposit that includes the Tesorito surface porphyry and the porphyry targets at Chuscal.

Ceibal is a new porphyry target with significant scale potential and forms part of the 100% owned Quinchia Gold Project in Colombia.

Porphyry deposits are one of the most important sources of copper and molybdenum. They are also major sources of silver, gold, and tin and may host valuable by-products including platinum, palladium, and tungsten.

As we reported on 29 March, Ceibal has emerged as an early-stage prospect, generating significant momentum to warrant its escalation as a new 2021 drill target.

Ceibal has a substantial, 800m x 600m gold, copper and molybdenum, surface soil and rock chip geochemistry anomaly (no artisanal workings are present) on the shoulder of an air magnetic anomaly.

Ceibal’s surface anomaly is broadly comparable in size and tenor to that of Tesorito.

Further to this, like Tesorito, Ceibal is located within the Marmato Fault Corridor at a structural dilation or “jog”.

In fact, Tesorito, Miraflores, Chuscal and Ceibal are all within, or very close to, the Marmato Fault Corridor, with one such fault set extending north from Quinchia to the 4 million ounce Marmato Gold Mine.

A field program launched last year logged outcrops and float of andesites and diorites similar to those encountered at Tesorito. Trenching results across the anomalous zone has added to the excitement of this new target with significant surface gold reported in three channels:

  • 90m @ 1.4g/t Au
  • 75m @ 1.2g/t Au (previously announced)
  • 25m @ 1.2g/t Au (previously announced)

The diamond rig has been transferred 1.5km NW from Chuscal to Ceibal for the initial program of scout holes.

“We are particularly excited about this new target as it has the surface fingerprint of classic porphyry occurrences,” Los Cerros Managing Director, Jason Stirbinskis said.

“So we have directed the Chuscal rig to Ceibal to start the process of understanding this compelling target. The timing is ideal as we have a backlog of Chuscal assays pending and this break to drill Ceibal will also allow us time to assimilate that pending data before planning subsequent Chuscal holes.

“The emergence of Ceibal and Tesorito West, the new deep intercept encountered while drilling southwest and below the Tesorito South porphyry, is further argument that the Quinchia Gold Project is another significant hot spot on the mid-Cauca gold belt which already hosts many multi-million-ounce discoveries.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X